APOLIPOPROTEIN B/A1

The Apolipoprotein B/A1 test measures the balance between atherogenic ApoB particles and protective ApoA1 particles—reported as a ratio—to give a sensitive assessment of cardiovascular risk that can be more informative than conventional lipid measures. Delivered as an in‑home service, a trained phlebotomist collects the blood sample (finger‑prick or venous draw depending on the laboratory), the sample is analyzed in an accredited lab and results are returned electronically for fast review and follow‑up in Dubai. This test is particularly useful for people with family history of heart disease, diabetes, metabolic syndrome, high cholesterol, or those on lipid‑lowering therapy to assess residual risk and guide treatment, but results should be interpreted by a qualified clinician.

• Apolipoprotein B (ApoB)
• Apolipoprotein A1 (ApoA1)
• ApoB/ApoA1 ratio

• Quantifies ApoB and ApoA1 and reports the ApoB/A1 ratio for precise cardiovascular risk stratification
• Convenient in-home finger‑prick or venous sample collection by qualified phlebotomists across Dubai
• Rapid laboratory processing with numeric results and clinical reference ranges for immediate interpretation
• Useful for monitoring response to statins or other lipid‑lowering therapies and refining risk in diabetes or metabolic syndrome
• Results issued from DHA‑approved UAE laboratories and formatted for easy sharing with your Dubai physician

• Quantifies Apolipoprotein B and Apolipoprotein A1 and provides the ApoB/A1 ratio for precise cardiovascular risk assessment
• In-home certified phlebotomist collection across Dubai for comfortable, convenient sample collection
• Rapid processing in accredited UAE laboratories with secure digital delivery of results within 24–48 hours
• Supports monitoring of lipid‑lowering therapy effectiveness and guides preventive heart‑health decisions
• Clinician-ready report with clear interpretation and recommended next steps tailored for UAE patients

• Quantitative ApoB/A1 ratio measured from a venous blood sample collected at home by a trained phlebotomist
• Improved cardiovascular risk stratification—more predictive of atherosclerotic risk than LDL-C alone
• Useful for baseline assessment and monitoring lipid-lowering therapy (statins, PCSK9) in adults; results readily shareable with UAE clinicians
• Fast laboratory turnaround with secure online reporting; fasting typically not required—follow the phlebotomist’s instructions